Johnson & Johnson to Participate in 2011 Citi Global Health Care Conference

NEW BRUNSWICK, N.J., Feb. 22, 2011 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 2011 Citi Global Health Care Conference on Tuesday, March 1, at the Hilton New York Hotel in New York, N.Y.  Joaquin Duato, Worldwide Chairman, Pharmaceuticals, will represent the Company in a session scheduled at 10:30 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.

SOURCE Johnson & Johnson

Suggested Articles

An oncologist leader RBC Capital Markets interviewed expressed comfort that Trodelvy will succeed in earlier-line TNBC and in HR-positive disease.

Gilead Sciences is the latest drugmaker to settle Justice Department claims that its charity contributions were actually kickbacks.

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.